Patrick Higgins
Analyst, Goodbody
Replay available
Greencore Group plc (LSE: GNC) Q4 2025 earnings conference call, held 2025-11-18. Replay captured from the company's public earnings webcast.

Analyst, Goodbody
Analyst, Davies
Analyst, Pill Hunt
Analyst, Jefferies
Analyst, Shore Capital
morning everybody and thank you for joining catherine and i for our fy25 results presentation it's great to be sharing a very set very strong set of results with you this morning our core business is in a great place with our commercial and operational excellence programs combined with our cost efficiency efforts providing the platform for us to reach a record level of profitability I'll start with some key messages, then we'll cover our financials and an operating review, and we'll close out on our acquisition of Backovil. So let's start with some key headlines on page five. Firstly, we're really proud of what we feel is an exceptional year of delivery. Catherine will share more. However, I did want to highlight the strong performance that we've had against every one of our financial medium term targets. In particular, we achieved a 15% ROIC, which is an increase of 350 basis points on FY24. Secondly, we continue to deliver for our customers on two things that are incredibly important to them, service and innovation. And these are two of the key elements that give us a competitive advantage in the market. Thirdly, against the subdued backdrop, we've had strong manufactured volume growth of 2.5%, which is well ahead of the overall grocery market. and we continue to take advantage of a number of structural tailwinds which we expect to continue through FY26 and beyond. Fourthly, we're driving this positive momentum into FY26 as we know there is a lot more opportunity to go after in our core business. Trading has started well and we anticipate another year of profitable growth ahead. Finally, regarding the acquisition of back of all, things are progressing to plan both in terms of the external support for the deal with the positive phase one decision from the CMA and ou...